Vident Investment Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $217K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.98M | Buy |
|
|||||
|
2021
Q4 | $1.19M | Sell |
|
|||||
|
2021
Q3 | $2.13M | Buy |
|
|||||
|
2021
Q2 | $1.76M | Sell |
|
|||||
|
2021
Q1 | $1.64M | Buy |
|
|||||
|
2020
Q4 | $1.42M | Buy |
|
|||||
|
2020
Q3 | $1.47M | Sell |
|
|||||
|
2020
Q2 | $1.53M | Buy |
|
|||||
|
2020
Q1 | $300K | Buy |
|
|||||
|
2019
Q4 | $276K | Sell |
|
|||||
|
2019
Q3 | $334K | Sell |
|
|||||
|
2019
Q2 | $397K | Sell |
|
|||||
|
2019
Q1 | $831K | Buy |
|
|||||
|
2018
Q4 | $537K | Sell |
|
|||||
|
2018
Q3 | $659K | Sell |
|
|||||
|
2018
Q2 | $751K | Buy |
|
|||||
|
2018
Q1 | $429K | Buy |
|
|||||
|
2017
Q4 | $262K | Buy |
|